LEF1 and diabetes mellitus: Expedited levels of LEF-1 in tumors coupled with high glucose levels in diabetic individuals promoting the LEF1–β-catenin complex formation is highly likely to accelerate malignant transformations, hinting at the prominent role of Wnt signaling in diabetes and cancer.